Physician profile
Oscar Ochoa
NPI 1871778928
$4,161.97
in general payments reported to CMS, 2019-2025
14 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $1,800 · 2021: $653 · 2022: $225 · 2023: $402 · 2024: $329 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.24 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $2,250.00 | 2020-2022 | |
| Abbvie INC. | $455.51 | 2023-2025 | |
| Allergan, INC. | $306.04 | 2019-2021 | |
| Tela Bio, INC. | $248.53 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $196.30 | 2024-2025 | Irrisept |
| Mentor Worldwide LLC | $173.12 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $148.98 | 2025 | |
| Kci USA, INC. | $121.10 | 2019 | |
| Olympus America INC. | $102.18 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $64.01 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Integra Lifesciences Corporation | $32.99 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $19.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Ochoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.